An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)Ruby Yun‐Ju Huang, Jean Paul Thiery|Cell Death and Disease|2013Cited by 467
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modificationVin Yee Chung, Ruby Yun‐Ju Huang|Scientific Reports|2016Cited by 163
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Alan Prem Kumar, Hiu Yan Lam et al.|Journal of Hematology & Oncology|2025Cited by 128
The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cellsVin Yee Chung, Ruby Yun‐Ju Huang|Communications Biology|2019Cited by 101
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Ruby Yun‐Ju Huang, Jean Paul Thiery|Oncotarget|2015Cited by 51